Interactive exhibition to reduce benzodiazepine use
Official title: Impact of an Interactive and Informative Exhibition on Benzodiazepine Use on Deprescription.
Run by Consorci Sanitari de l'Alt Penedès i Garraf · NCT06467019 · Data updated 2026-11-12
This study tests if an interactive exhibition in a clinic waiting room can help adults use fewer benzodiazepines by educating them about the risks of long-term use.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 6410 (estimated) |
| Sponsor | Consorci Sanitari de l'Alt Penedès i Garraf Academic / other |
| Locations | 1 site (Vilanova i la Geltrú, Barcelona) |
| Status | Recruiting |
| Started | June 13, 2024 |
| Main results expected | July 2027 |
| Study ends | July 2027 |
| Registry record updated | October 27, 2026 |
| Trial ID | NCT06467019 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 99 who attend the Baix-a-Mar Primary Care Center.
✕Probably not a fit
Patients with severe mental health diseases or those not assigned to a doctor at the center may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial aims to assess whether an interactive and informative exhibition in a Primary Care Clinic's waiting room can decrease benzodiazepine consumption among adults. Researchers will compare the usage of benzodiazepines before and after the exhibition is implemented. Participants will engage with materials highlighting the risks associated with chronic benzodiazepine use, while health professionals will also receive a single informative session on the topic.
Why it matters
Potential benefit: If successful, this approach could lead to a significant reduction in benzodiazepine use, improving patient safety and health outcomes.
How similar studies have gone: While there is limited data on similar interactive approaches, previous studies have shown that educational interventions can effectively reduce medication use.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women between 18 and 99 years of age. * Attended at the Baix-a-Mar Primary Care Center during the study period. Exclusion Criteria: * Severe mental health disease * Displaced patients or those who do not have an assigned doctor at the center. * Participation in another study involving an experimental intervention during the period of the present study that affects benzodiazepine prescription.
Where it's running
-
Centro de Salud Vilanova i la Geltrú 3 Baix A Mar
Vilanova i la Geltrú, Barcelona, Spain Recruiting
Study contacts
- Principal investigator: Jordi Milozzi, MD — Centro de Salud Vilanova i la Geltrú 3 Baix A Mar-CSAPG
- Study coordinator: Jordi Milozzi, MD
- Email: jmilozzi@csapg.cat
- Phone: +34 938 10 30 03
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Silver Diamine Fluoride for Caries in Baby Teeth in Routine Dental Care
This study tests whether applying 38% silver diamine fluoride in everyday dental practice can stop decay in primary teeth of children 14 and younger.
-
How a patient experience check-in helps people in intermediate and long-term care feel more trusted in the hospital
This study tests whether identifying and acting on patient concerns in intermediate and long-term care units can help older patients trust the hospital more and reduce complaints.
-
Impact of External Workplace Violence on Healthcare Workers’ Well-being
This study tests whether workplace violence from patients, relatives, or companions is linked to worse well-being among healthcare workers who interact with the public.
-
Dietitian-led follow-up versus day-hospital endocrinology care for improving blood sugar in type 2 diabetes
This project will test whether follow-up by a dietitian-nutritionist or care in a day hospital leads to better three-month HbA1c in people with type 2 diabetes who are on insulin and have poor blood sugar control.
-
Loneliness linked to dementia risk in older adults with mild cognitive impairment
This study will look to see if loneliness is associated with a higher chance of developing dementia within 12 months in people aged 70 and older who have mild cognitive impairment.
-
Tofacitinib in Juvenile Idiopathic Arthritis
This study looks at real-world use of tofacitinib to see if it helps control Juvenile Idiopathic Arthritis in kids over about 12 months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.